Archives
3X (DYKDDDDK) Peptide: Precision Epitope Tag for Affinity...
3X (DYKDDDDK) Peptide: Precision Epitope Tag for Affinity Purification and Immunodetection
Executive Summary: The 3X (DYKDDDDK) Peptide is a synthetic tag comprising three tandem DYKDDDDK motifs, totaling 23 amino acids. It enables high-sensitivity detection and efficient affinity purification of recombinant proteins via monoclonal anti-FLAG antibodies (M1/M2) (Nucleic Acids Research, 2024). Its hydrophilic nature ensures minimal disruption to protein structure and function. The peptide is highly soluble in TBS buffer (≥25 mg/ml at 0.5M Tris-HCl, pH 7.4, 1M NaCl), supporting workflows in immunodetection, protein crystallization, and metal-dependent ELISA. Calcium ions modulate antibody-peptide interactions, informing assay design. (Product A6001).
Biological Rationale
The need for precise detection and purification of recombinant proteins drives the adoption of epitope tags like the 3X (DYKDDDDK) Peptide. The DYKDDDDK sequence (FLAG tag) is recognized by high-affinity monoclonal antibodies, such as M1 and M2, allowing selective capture and detection of fusion proteins (Nucleic Acids Research, 2024). Triple-repeat designs (3X FLAG) increase tag accessibility and antibody binding, especially in complex samples or low-abundance targets. The tag’s hydrophilicity reduces the risk of altering protein folding or function, compared to larger or more hydrophobic tags. This property is critical for applications like protein crystallization, where structural integrity is paramount (CEP-32496, 2024). The 3X FLAG peptide also facilitates studies of protein–protein interactions and post-translational modifications due to its compatibility with diverse biochemical conditions.
Mechanism of Action of 3X (DYKDDDDK) Peptide
The 3X (DYKDDDDK) Peptide consists of three direct repeats of the DYKDDDDK motif, yielding a linear, hydrophilic 23-residue peptide (sequence: MDYKDHDGDYKDHDIDYKDDDDK) (Product Datasheet). When fused to a target protein, the tag is exposed on the protein surface, maximizing accessibility for anti-FLAG monoclonal antibodies. The tag’s high affinity for M1 and M2 antibodies enables selective immunoprecipitation and detection (FUT-175, 2024).
Calcium ions (≥1 mM CaCl2) enhance the binding affinity of M1 antibodies for the FLAG epitope, a property leveraged in metal-dependent ELISA and co-crystallization protocols (Nucleic Acids Research, 2024). The peptide’s hydrophilicity and compact size (<2.5 kDa) minimize steric hindrance, preserving the structural and functional properties of the tagged protein (L3400, 2024).
Evidence & Benchmarks
- 3X FLAG tag increases immunodetection sensitivity of fusion proteins compared to single FLAG tags (https://doi.org/10.1093/nar/gkae963).
- Affinity purification using anti-FLAG resin yields >95% purity for FLAG-tagged proteins in TBS buffer (0.5M Tris-HCl, pH 7.4, 1M NaCl) (https://www.apexbt.com/3x-flag-peptide.html).
- Peptide is stable for several months at -80°C when aliquoted and desiccated (https://www.apexbt.com/3x-flag-peptide.html).
- Calcium-dependent ELISA demonstrates >3-fold increase in antibody binding affinity at 2 mM CaCl2 (https://doi.org/10.1093/nar/gkae963).
- Hydrophilic tag does not interfere with crystallization trials or protein folding (https://type-ii-collagen-fragment.com/...).
Applications, Limits & Misconceptions
The 3X (DYKDDDDK) Peptide is used in:
- Affinity purification of FLAG-tagged proteins in prokaryotic and eukaryotic systems.
- Immunodetection (western blot, ELISA, immunofluorescence) of fusion proteins at low abundance.
- Protein crystallization workflows where minimal tag interference is required (L3400, 2024).
- Metal-dependent ELISA for studying antibody-epitope interactions (Bridgene, 2024).
- Investigating regulated protein degradation and proteostasis mechanisms.
Common Pitfalls or Misconceptions
- The 3X FLAG peptide will not bind to polyclonal antibodies that lack FLAG specificity; only monoclonal M1/M2 anti-FLAG antibodies are suitable for optimal detection (Nucleic Acids Research, 2024).
- Excessive peptide concentrations (>25 mg/ml) may exceed solubility in non-TBS buffers or at lower ionic strength.
- Calcium-dependent binding enhancement is specific to M1 and may not generalize to all anti-FLAG antibody clones.
- The tag does not confer resistance to proteolysis if fused to unstable protein regions.
- The 3X FLAG tag does not facilitate purification of non-FLAG-tagged proteins or endogenous targets.
This article extends prior explanations in CEP-32496 by detailing stable storage conditions and solubility thresholds, which are not covered in depth in earlier summaries of immune signaling workflows. It also clarifies the calcium-dependence of M1 antibody binding, updating the protein interaction focus from FUT-175.
Workflow Integration & Parameters
Storage and Handling: Store the lyophilized peptide desiccated at -20°C. For working solutions, aliquot in TBS buffer (0.5M Tris-HCl, pH 7.4, 1M NaCl) and store at -80°C. Avoid repeated freeze-thaw cycles to preserve integrity (A6001 datasheet).
Concentration: Peptide is soluble at ≥25 mg/ml in TBS buffer under standard conditions.
Assay Optimization: For immunoprecipitation, incubate lysates with anti-FLAG M2-agarose at 4°C for 1–2 hours. For ELISA, include 1–2 mM CaCl2 to maximize M1 antibody binding. Elute with excess FLAG peptide (100–200 μg/ml) or adjust ionic strength as required.
Compatibility: The 3X (DYKDDDDK) Peptide is compatible with major mammalian and bacterial expression systems. It does not disrupt target protein folding or activity (L3400, 2024).
Conclusion & Outlook
The 3X (DYKDDDDK) Peptide represents a high-precision, low-interference tool for the selective purification and detection of recombinant proteins. Its robust solubility, antibody accessibility, and metal-ion-mediated binding modulation enable advanced applications across structural biology, proteomics, and immunology. Future developments may leverage engineered variants or multiplexed tags for even greater specificity and multiplexing capacity (Nucleic Acids Research, 2024).